Straits Times Index
3,182.84+2.23(+0.07%)Nikkei
27,345.72-436.70(-1.57%)Hang Seng
25,760.77-554.55(-2.11%)FTSE 100
7,078.42+61.79(+0.88%)BTC-USD
40,021.14+441.38(+1.12%)CMC Crypto 200
951.96+21.60(+2.32%)
The Fight Against COVID19
21.50k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The Fight Against COVID19 | -1.37% | - | - | - |
| ^GSPC | +0.42% | +2.83% | +36.13% | +4651.77% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 172.18 | - | - | 4:00 pm GMT-4 | 4.09M | 6.66M | 453.42B |
| PFE | Pfizer Inc. | 42.79 | -0.27 | -0.63% | 4:03 pm GMT-4 | 28.70M | 25.82M | 239.53B |
| ABBV | AbbVie Inc. | 118.87 | +0.32 | +0.27% | 4:02 pm GMT-4 | 4.48M | 6.35M | 209.95B |
| MRNA | Moderna, Inc. | 345.64 | -3.68 | -1.05% | 4:00 pm GMT-4 | 10.10M | 12.95M | 138.78B |
| SNY | Sanofi | 51.53 | -0.53 | -1.02% | 4:00 pm GMT-4 | 1.92M | 1.34M | 129.09B |
| GSK | GlaxoSmithKline plc | 40.1 | +0.60 | +1.52% | 4:00 pm GMT-4 | 5.34M | 4.30M | 100.89B |
| GILD | Gilead Sciences, Inc. | 69.83 | -0.23 | -0.33% | 4:00 pm GMT-4 | 6.95M | 6.72M | 87.58B |
| BNTX | BioNTech SE | 312.59 | -0.86 | -0.27% | 4:00 pm GMT-4 | 4.06M | 3.24M | 75.50B |
| REGN | Regeneron Pharmaceuticals, Inc. | 583.13 | -3.28 | -0.56% | 4:00 pm GMT-4 | 361.43k | 752.26k | 62.13B |
| TAK | Takeda Pharmaceutical Company Limited | 16.93 | -0.20 | -1.17% | 4:00 pm GMT-4 | 2.70M | 2.03M | 53.38B |
| NVAX | Novavax, Inc. | 184 | -5.01 | -2.65% | 4:00 pm GMT-4 | 2.41M | 4.22M | 13.63B |
| VIR | Vir Biotechnology, Inc. | 36.39 | -0.66 | -1.78% | 4:00 pm GMT-4 | 479.16k | 720.05k | 4.73B |
| INO | Inovio Pharmaceuticals, Inc. | 8.5 | -0.17 | -1.96% | 4:00 pm GMT-4 | 2.20M | 5.40M | 1.78B |
- Editor's pickYahoo Finance Video
We must move towards vaccine mandates to get ahead of Covid-19: Doctor
Dr. Anand Swaminathan, Emergency Medicine Physician in New Jersey, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
- Reuters
UPDATE 4-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant
Emergent BioSolutions said it will resume production of Johnson & Johnson's COVID-19 vaccine at its troubled Baltimore facility, where operations were stopped in April after millions of doses were found to be contaminated. Last week, J&J slashed 2021 production target of its single-dose vaccine to between 500 million and 600 million doses from its original goal to produce a billion shots. The resumption follows additional reviews and collaboration with the FDA and manufacturing partners, Emergent Chief Executive Officer Robert Kramer said.
- Business Wire
GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps
LONDON, July 29, 2021--GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps.
